These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 37691931)

  • 21. Metabolome analysis for investigating host-gut microbiota interactions.
    Chen MX; Wang SY; Kuo CH; Tsai IL
    J Formos Med Assoc; 2019 Mar; 118 Suppl 1():S10-S22. PubMed ID: 30269936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrative analysis of microbiome and metabolome reveals the linkage between gut microbiota and carp growth.
    Nie Z; Xu X; Shao N; He J; Li P; Xu P; Hu J; Qin W; Wang B; Xu G
    Environ Res; 2023 Mar; 220():115133. PubMed ID: 36563984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The intricate connection between diet, microbiota, and cancer: A jigsaw puzzle.
    Arkan MC
    Semin Immunol; 2017 Aug; 32():35-42. PubMed ID: 28870704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Established Cotton Stainer Gut Bacterial Mutualists Evade Regulation by Host Antimicrobial Peptides.
    Onchuru TO; Kaltenpoth M
    Appl Environ Microbiol; 2019 Jul; 85(13):. PubMed ID: 31028027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The intestinal 3M (microbiota, metabolism, metabolome) zeitgeist - from fundamentals to future challenges.
    Dey P; Chaudhuri SR; Efferth T; Pal S
    Free Radic Biol Med; 2021 Nov; 176():265-285. PubMed ID: 34610364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Network Analysis of Gut Microbiome and Metabolome to Discover Microbiota-Linked Biomarkers in Patients Affected by Non-Small Cell Lung Cancer.
    Vernocchi P; Gili T; Conte F; Del Chierico F; Conta G; Miccheli A; Botticelli A; Paci P; Caldarelli G; Nuti M; Marchetti P; Putignani L
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33227982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of the gut microbiome on toxigenic bacteria.
    Koosha RZ; Fazel P; Sedighian H; Behzadi E; Ch MH; Imani Fooladi AA
    Microb Pathog; 2021 Nov; 160():105188. PubMed ID: 34530074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms underlying gut microbiota-host interactions in insects.
    Schmidt K; Engel P
    J Exp Biol; 2021 Jan; 224(Pt 2):. PubMed ID: 33509844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of the gut microbiota in the treatment of inflammatory bowel diseases.
    Aggeletopoulou I; Konstantakis C; Assimakopoulos SF; Triantos C
    Microb Pathog; 2019 Dec; 137():103774. PubMed ID: 31586663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging role of microbiota in immunomodulation and cancer immunotherapy.
    Singh RP; Bashir H; Kumar R
    Semin Cancer Biol; 2021 May; 70():37-52. PubMed ID: 32580024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut Microbiota in Tumor Microenvironment: A Critical Regulator in Cancer Initiation and Development as Potential Targets for Chinese Medicine.
    Wang L; Peng F; Peng C; Du JR
    Am J Chin Med; 2021; 49(3):609-626. PubMed ID: 33683187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human Genes Involved in the Interaction between Host and Gut Microbiome: Regulation and Pathogenic Mechanisms.
    Boccuto L; Tack J; Ianiro G; Abenavoli L; Scarpellini E
    Genes (Basel); 2023 Mar; 14(4):. PubMed ID: 37107615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic microbiome and metabolome analyses reveal the interaction between gut microbiota and anti-PD-1 based immunotherapy in hepatocellular carcinoma.
    Wu H; Zheng X; Pan T; Yang X; Chen X; Zhang B; Peng L; Xie C
    Int J Cancer; 2022 Oct; 151(8):1321-1334. PubMed ID: 35579980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Potential of the Gut Microbiome to Reshape the Cancer Therapy Paradigm: A Review.
    Liu L; Shah K
    JAMA Oncol; 2022 Jul; 8(7):1059-1067. PubMed ID: 35482355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of gut microbiome in the development and treatment of pancreatic cancer: Newer insights.
    Bangolo AI; Trivedi C; Jani I; Pender S; Khalid H; Alqinai B; Intisar A; Randhawa K; Moore J; De Deugd N; Faisal S; Suresh SB; Gopani P; Nagesh VK; Proverbs-Singh T; Weissman S
    World J Gastroenterol; 2023 Jul; 29(25):3984-3998. PubMed ID: 37476590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations of host-gut microbiome interactions in multiple sclerosis.
    Cantoni C; Lin Q; Dorsett Y; Ghezzi L; Liu Z; Pan Y; Chen K; Han Y; Li Z; Xiao H; Gormley M; Liu Y; Bokoliya S; Panier H; Suther C; Evans E; Deng L; Locca A; Mikesell R; Obert K; Newland P; Wu Y; Salter A; Cross AH; Tarr PI; Lovett-Racke A; Piccio L; Zhou Y
    EBioMedicine; 2022 Feb; 76():103798. PubMed ID: 35094961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of gut microbiota on immune responses and immunotherapy in colorectal cancer.
    Hou X; Zheng Z; Wei J; Zhao L
    Front Immunol; 2022; 13():1030745. PubMed ID: 36426359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The crosstalk between the gut microbiota and tumor immunity: Implications for cancer progression and treatment outcomes.
    Wang M; Zhang L; Chang W; Zhang Y
    Front Immunol; 2022; 13():1096551. PubMed ID: 36726985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response.
    Shen Y; Wu SD; Chen Y; Li XY; Zhu Q; Nakayama K; Zhang WQ; Weng CZ; Zhang J; Wang HK; Wu J; Jiang W
    Gut Microbes; 2023; 15(1):2155018. PubMed ID: 36519342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Research progress on the regulation of mammalian energy metabolism by the circadian clock system and gut microbiota].
    Zhang HS; Li C; Li YT; Jin YP; Liu W; Chen HT
    Sheng Li Xue Bao; 2022 Jun; 74(3):443-460. PubMed ID: 35770642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.